Literature DB >> 31202288

A scalable, automated warm handoff from the emergency department to community sites offering continued medication for opioid use disorder: Lessons learned from the EMBED trial stakeholders.

Osama M Ahmed1, Jodi A Mao2, Stephen R Holt3, Kathryn Hawk4, Gail D'Onofrio4, Shara Martel4, Edward R Melnick5.   

Abstract

BACKGROUND: In order to streamline the emergency department (ED) referral process in a multi-network automated opioid treatment referral program, we performed a needs assessment of community providers for Medication for Opioid Use Disorder (MOUD) in the EMergency department-initiated BuprenorphinE for opioid use Disorder (EMBED) trial network.
METHODS: A needs assessment was conducted in two phases: (1) key stakeholder meetings and (2) a survey of community sites offering MOUD. Stakeholder meetings were conducted with five key stakeholder groups: 1) ED clinicians and staff, 2) community sites offering MOUD, 3) the investigative team, 4) health system IT staff, and 5) medical ethics experts. Meetings continued until each stakeholder group stated that their priorities and needs were understood. Major categories of needs were extracted pragmatically based on recurrence across stakeholder groups. Informed by needs expressed by IT and MOUD site stakeholders, nineteen MOUD sites were surveyed to better characterize information needs of community sites offering MOUD when receiving an ED referral.
RESULTS: Three major categories of needs for referral system were identified: 1) The system to be automated, flexible and allow multiple channels of referral, 2) Referral metrics are retrievable in a HIPAA compliant manner, 3) Patients are scheduled into community sites offering MOUD as urgently as possible. Of the MOUD sites surveyed, 68.4% (13/19) responded. Based on the responses, specific patient identifiers were required for most MOUD site referrals, and encrypted emails and EHR were the preferred methods of communication for the handoff. 53.8% (7/13) of the sites were able to accept patients within 3 days with only 1 site requiring >7 days.
CONCLUSION: These findings can inform IT solutions to address the discordant priorities of the ED (rapid and flexible referral process) and the community sites offering (referrals minimize variability and overbooking). To prevent drop-out in the referral cascade, our findings emphasize the need for increased availability and accessibility to MOUD on demand and protected communication channels between EDs and community providers of MOUD.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Medication assisted treatment; Medication for addiction treatment; Medication for opioid use disorder; Opioid use disorder; Referral

Mesh:

Substances:

Year:  2019        PMID: 31202288      PMCID: PMC6578846          DOI: 10.1016/j.jsat.2019.05.006

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  18 in total

1.  1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.

Authors:  Johan Kakko; Kerstin Dybrandt Svanborg; Mary Jeanne Kreek; Markus Heilig
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

2.  Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.

Authors:  Paul M Roman; Amanda J Abraham; Hannah K Knudsen
Journal:  Addict Behav       Date:  2011-01-27       Impact factor: 3.913

Review 3.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2014-02-06

4.  Barriers to primary care physicians prescribing buprenorphine.

Authors:  Eliza Hutchinson; Mary Catlin; C Holly A Andrilla; Laura-Mae Baldwin; Roger A Rosenblatt
Journal:  Ann Fam Med       Date:  2014 Mar-Apr       Impact factor: 5.166

5.  Medication-assisted therapies--tackling the opioid-overdose epidemic.

Authors:  Nora D Volkow; Thomas R Frieden; Pamela S Hyde; Stephen S Cha
Journal:  N Engl J Med       Date:  2014-04-23       Impact factor: 91.245

6.  Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital.

Authors:  Chinazo O Cunningham; Nancy L Sohler; Kate McCoy; Hillary V Kunins
Journal:  Fam Med       Date:  2006-05       Impact factor: 1.756

7.  Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence.

Authors:  Wendy Kissin; Caroline McLeod; Joseph Sonnefeld; Arlene Stanton
Journal:  J Addict Dis       Date:  2006

8.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.

Authors:  Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

Review 9.  Narrative review: buprenorphine for opioid-dependent patients in office practice.

Authors:  Lynn E Sullivan; David A Fiellin
Journal:  Ann Intern Med       Date:  2008-05-06       Impact factor: 25.391

10.  Office-based management of opioid dependence with buprenorphine: clinical practices and barriers.

Authors:  Alexander Y Walley; Julie K Alperen; Debbie M Cheng; Michael Botticelli; Carolyn Castro-Donlan; Jeffrey H Samet; Daniel P Alford
Journal:  J Gen Intern Med       Date:  2008-09       Impact factor: 5.128

View more
  9 in total

1.  Review, Assess, Classify, and Evaluate (RACE): a framework for studying m-health apps and its application for opioid apps.

Authors:  Upkar Varshney; Neetu Singh; Anu G Bourgeois; Shanta R Dube
Journal:  J Am Med Inform Assoc       Date:  2022-01-29       Impact factor: 4.497

2.  Progress Report on EMBED: A Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder.

Authors:  Edward R Melnick; Bidisha Nath; Osama M Ahmed; Cynthia Brandt; David Chartash; James D Dziura; Erik P Hess; Wesley C Holland; Jason A Hoppe; Molly M Jeffery; Liliya Katsovich; Fangyong Li; Charles C Lu; Kaitlin Maciejewski; Matthew Maleska; Jodi A Mao; Shara Martel; Sean Michael; Hyung Paek; Mehul D Patel; Timothy F Platts-Mills; Haseena Rajeevan; Jessica M Ray; Rachel M Skains; William E Soares; Ashley Deutsch; Yauheni Solad; Gail D'Onofrio
Journal:  J Psychiatr Brain Sci       Date:  2020-02-21

3.  An integrated web application for decision support and automation of EHR workflow: a case study of current challenges to standards-based messaging and scalability from the EMBED trial.

Authors:  Edward R Melnick; Wesley C Holland; Osama M Ahmed; Anthony K Ma; Sean S Michael; Howard S Goldberg; Christian Lagier; Gail D'Onofrio; Tomek Stachowiak; Cynthia Brandt; Yauheni Solad
Journal:  JAMIA Open       Date:  2019-10-14

4.  Interrupted Time Series of User-centered Clinical Decision Support Implementation for Emergency Department-initiated Buprenorphine for Opioid Use Disorder.

Authors:  Wesley C Holland; Bidisha Nath; Fangyong Li; Kaitlin Maciejewski; Hyung Paek; James Dziura; Haseena Rajeevan; Charles C Lu; Liliya Katsovich; Gail D'Onofrio; Edward R Melnick
Journal:  Acad Emerg Med       Date:  2020-05-19       Impact factor: 3.451

5.  Breaching Trust: A Qualitative Study of Healthcare Experiences of People Who Use Drugs in a Rural Setting.

Authors:  Kaitlin Ellis; Suzan Walters; Samuel R Friedman; Lawrence J Ouellet; Jerel Ezell; Kris Rosentel; Mai T Pho
Journal:  Front Sociol       Date:  2020-11-10

6.  Development of an Emergency Department-Based Intervention to Expand Access to Medications for Opioid Use Disorder in a Medicaid Nonexpansion Setting: Protocol for Engagement and Community Collaboration.

Authors:  Lauren A Walter; Li Li; Erik P Hess; Joel B Rodgers; Jennifer J Hess; Rachel M Skains; Matthew C Delaney; James Booth
Journal:  JMIR Res Protoc       Date:  2021-04-29

7.  User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial.

Authors:  Edward R Melnick; Bidisha Nath; James D Dziura; Martin F Casey; Molly M Jeffery; Hyung Paek; William E Soares; Jason A Hoppe; Haseena Rajeevan; Fangyong Li; Rachel M Skains; Lauren A Walter; Mehul D Patel; Srihari V Chari; Timothy F Platts-Mills; Erik P Hess; Gail D'Onofrio
Journal:  BMJ       Date:  2022-06-27

8.  Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions.

Authors:  Timothy D Kelly; Kathryn F Hawk; Elizabeth A Samuels; Reuben J Strayer; Jason A Hoppe
Journal:  West J Emerg Med       Date:  2022-07-11

9.  Advancing emergency department-initiated buprenorphine.

Authors:  Kristen Huntley; Emily Einstein; Terri Postma; Anita Thomas; Shari Ling; Wilson Compton
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-06-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.